Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Technologies Limited (ITL) was a pioneering medical technology company based in Winsford, UK, that specialized in the development and manufacture of advanced wound care products. The company was a global leader in hydrogel and foam technologies, providing innovative solutions for the management of chronic and acute wounds, including pressure sores and diabetic ulcers. ITL's expertise in polymer chemistry and moisture-responsive materials led to the creation of high-performance dressings that significantly improved patient outcomes and healing rates. In 2002, the company was acquired by Smith & Nephew for approximately £45 million, becoming a core component of their world-leading Advanced Wound Management division. Today, the technologies developed by ITL continue to underpin several of the most successful wound care brands in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Technologies.